InnoCan Pharma Corporation (INNO.CN)
CAD 0.19
(-7.5%)
CAD 0.19
(-7.5%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -3.77 Million USD | 39.29% |
| 2022 | -3.85 Million USD | 16.5% |
| 2021 | -10.03 Million USD | -58.74% |
| 2020 | -9.9 Million USD | -57.32% |
| 2019 | -2.97 Million USD | -155.4% |
| 2018 | - USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -357 Thousand USD | 144.98% |
| 2024 Q1 | -1.2 Million USD | -36.0% |
| 2023 Q4 | -886 Thousand USD | 25.98% |
| 2023 FY | - USD | 39.29% |
| 2023 Q1 | -1.24 Million USD | -266.53% |
| 2023 Q2 | -424 Thousand USD | 66.05% |
| 2023 Q3 | -1.19 Million USD | -182.31% |
| 2022 Q3 | -1.94 Million USD | 0.71% |
| 2022 Q2 | -1.96 Million USD | -8.58% |
| 2022 FY | - USD | 16.5% |
| 2022 Q1 | -1.8 Million USD | 62.82% |
| 2022 Q4 | 750 Thousand USD | 138.52% |
| 2021 FY | - USD | -58.74% |
| 2021 Q4 | -4.85 Million USD | -200.99% |
| 2021 Q3 | -1.61 Million USD | -74.11% |
| 2021 Q2 | -927 Thousand USD | 62.77% |
| 2021 Q1 | -2.49 Million USD | -100.32% |
| 2020 Q2 | -1.4 Million USD | -441.31% |
| 2020 Q1 | -259 Thousand USD | 68.87% |
| 2020 FY | - USD | -57.32% |
| 2020 Q4 | -1.24 Million USD | -11.88% |
| 2020 Q3 | -1.11 Million USD | 20.76% |
| 2019 Q3 | -1.52 Million USD | -415.59% |
| 2019 Q2 | -295 Thousand USD | 1.99% |
| 2019 Q1 | -301 Thousand USD | 54.53% |
| 2019 Q4 | -832 Thousand USD | 45.3% |
| 2019 FY | - USD | -155.4% |
| 2018 Q4 | -662 Thousand USD | -147.94% |
| 2018 Q3 | -267 Thousand USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 37.929% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | -87.516% |
| Blueberries Medical Corp. | -1.22 Million CAD | -208.564% |
| The BC Bud Corporation | -1.19 Million CAD | -215.214% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 41.862% |
| CordovaCann Corp. | -1.6 Million CAD | -135.24% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | -43.704% |
| Captor Capital Corp. | 2.42 Million CAD | 255.71% |
| City View Green Holdings Inc. | -2.01 Million CAD | -87.147% |
| 1CM Inc. | 1.31 Million CAD | 387.014% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | -15105.905% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | -70.712% |
| IM Cannabis Corp. | -2.79 Million CAD | -35.125% |
| Lobe Sciences Ltd. | -4.4 Million CAD | 14.363% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -861.205% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | -18.071% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | 430.238% |
| Ovation Science Inc. | -778.83 Thousand CAD | -384.058% |
| Pharmadrug Inc. | -1.33 Million CAD | -182.394% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | 37.749% |
| RAMM Pharma Corp. | -6.3 Million CAD | 40.179% |
| RIV Capital Inc. | -20.28 Million CAD | 81.411% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | 32.618% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 95.141% |
| SLANG Worldwide Inc. | -2.95 Million CAD | -27.766% |
| 1933 Industries Inc. | -10.03 Million CAD | 62.424% |
| Red Light Holland Corp. | -5.25 Million CAD | 28.27% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | -390.89% |
| Xebra Brands Ltd. | -1.49 Million CAD | -152.175% |
| Adastra Holdings Ltd. | -1.41 Million CAD | -167.136% |